225 related articles for article (PubMed ID: 12495558)
1. Inhibition and possible induction of rat CYP2D after short- and long-term treatment with antidepressants.
Daniel WA; Haduch A; Wójcikowski J
J Pharm Pharmacol; 2002 Nov; 54(11):1545-52. PubMed ID: 12495558
[TBL] [Abstract][Full Text] [Related]
2. The effect of tricyclic antidepressants, selective serotonin reuptake inhibitors (SSRIs) and newer antidepressant drugs on the activity and level of rat CYP3A.
Haduch A; Wójcikowski J; Daniel WA
Eur Neuropsychopharmacol; 2006 Apr; 16(3):178-86. PubMed ID: 16246530
[TBL] [Abstract][Full Text] [Related]
3. Direct and indirect interactions between antidepressant drugs and CYP2C6 in the rat liver during long-term treatment.
Daniel WA; Haduch A; Syrek M; Boksa J
Eur Neuropsychopharmacol; 2006 Dec; 16(8):580-7. PubMed ID: 16503401
[TBL] [Abstract][Full Text] [Related]
4. Effect of short- and long-term treatment with antidepressant drugs on the activity of rat CYP2A in the liver.
Haduch A; Wójcikowski J; Daniel WA
Pharmacol Rep; 2005; 57(6):774-81. PubMed ID: 16382196
[TBL] [Abstract][Full Text] [Related]
5. Effect of selected antidepressant drugs on cytochrome P450 2B (CYP2B) in rat liver. An in vitro and in vivo study.
Haduch A; Wójcikowski J; Daniel WA
Pharmacol Rep; 2008; 60(6):957-65. PubMed ID: 19211989
[TBL] [Abstract][Full Text] [Related]
6. Effect of antidepressant drugs on cytochrome P450 2C11 (CYP2C11) in rat liver.
Wójcikowski J; Haduch A; Daniel WA
Pharmacol Rep; 2013; 65(5):1247-55. PubMed ID: 24399720
[TBL] [Abstract][Full Text] [Related]
7. Caffeine metabolism during prolonged treatment of rats with antidepressant drugs.
Kot M; Wójcikowski J; Daniel WA
Pharmacol Rep; 2007; 59(6):727-33. PubMed ID: 18195463
[TBL] [Abstract][Full Text] [Related]
8. Effects of classic and newer antidepressants on the oxidation pathways of caffeine in rat liver. In vitro study.
Daniel WA; Kot M; Wójcikowski J
Pol J Pharmacol; 2003; 55(6):1045-53. PubMed ID: 14730100
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of rat liver CYP2D in vitro and after 1-day and long-term exposure to neuroleptics in vivo-possible involvement of different mechanisms.
Daniel WA; Haduch A; Wójcikowski J
Eur Neuropsychopharmacol; 2005 Jan; 15(1):103-10. PubMed ID: 15572279
[TBL] [Abstract][Full Text] [Related]
10. Venlafaxine: in vitro inhibition of CYP2D6 dependent imipramine and desipramine metabolism; comparative studies with selected SSRIs, and effects on human hepatic CYP3A4, CYP2C9 and CYP1A2.
Ball SE; Ahern D; Scatina J; Kao J
Br J Clin Pharmacol; 1997 Jun; 43(6):619-26. PubMed ID: 9205822
[TBL] [Abstract][Full Text] [Related]
11. The effect of psychotropic drugs on cytochrome P450 2D (CYP2D) in rat brain.
Haduch A; Bromek E; Daniel WA
Eur J Pharmacol; 2011 Jan; 651(1-3):51-8. PubMed ID: 21115002
[TBL] [Abstract][Full Text] [Related]
12. Effects of antidepressant drugs on the activity of cytochrome P-450 measured by caffeine oxidation in rat liver microsomes.
Danie WA; Syrek M; Ryłko Z; Wójcikowski J
Pol J Pharmacol; 2001; 53(4):351-7. PubMed ID: 11990081
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding.
Sánchez C; Hyttel J
Cell Mol Neurobiol; 1999 Aug; 19(4):467-89. PubMed ID: 10379421
[TBL] [Abstract][Full Text] [Related]
14. The influence of selective serotonin reuptake inhibitors (SSRIs) on the pharmacokinetics of thioridazine and its metabolites: in vivo and in vitro studies.
Daniel WA; Syrek M; Haduch A; Wójcikowski J
Exp Toxicol Pathol; 1999 Jul; 51(4-5):309-14. PubMed ID: 10445388
[TBL] [Abstract][Full Text] [Related]
15. Antidepressant drug interactions and the cytochrome P450 system. The role of cytochrome P450 2D6.
Ereshefsky L; Riesenman C; Lam YW
Clin Pharmacokinet; 1995; 29 Suppl 1():10-8; discussion 18-9. PubMed ID: 8846618
[TBL] [Abstract][Full Text] [Related]
16. Effects of chronic treatment with classic and newer antidepressants and neuroleptics on the activity and level of CYP2D in the rat brain.
Haduch A; Wójcikowski J; Daniel WA
Pol J Pharmacol; 2004; 56(6):857-62. PubMed ID: 15662101
[TBL] [Abstract][Full Text] [Related]
17. Metabolism of the newer antidepressants. An overview of the pharmacological and pharmacokinetic implications.
Caccia S
Clin Pharmacokinet; 1998 Apr; 34(4):281-302. PubMed ID: 9571301
[TBL] [Abstract][Full Text] [Related]
18. Antidepressants inhibit human acetylcholinesterase and butyrylcholinesterase activity.
Müller TC; Rocha JB; Morsch VM; Neis RT; Schetinger MR
Biochim Biophys Acta; 2002 May; 1587(1):92-8. PubMed ID: 12009429
[TBL] [Abstract][Full Text] [Related]
19. Phenacetin O-deethylation by human liver microsomes in vitro: inhibition by chemical probes, SSRI antidepressants, nefazodone and venlafaxine.
von Moltke LL; Greenblatt DJ; Duan SX; Schmider J; Kudchadker L; Fogelman SM; Harmatz JS; Shader RI
Psychopharmacology (Berl); 1996 Dec; 128(4):398-407. PubMed ID: 8986010
[TBL] [Abstract][Full Text] [Related]
20. Effect of mirtazapine on the CYP2D activity in the primary culture of rat hepatocytes.
Haduch A; Bromek E; Kot M; Jemnitz K; Veres Z; Vereczkey L; Daniel WA
Pharmacol Rep; 2006; 58(6):979-84. PubMed ID: 17220559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
